Article Details
Retrieved on: 2017-12-07 23:22:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Finally, <b>Renaissance Technologies</b> LLC lifted its position in shares of Protalix Biotherapeutics by 302.1% in the first quarter. <b>Renaissance Technologies</b> LLC now owns 1,927,500 shares of the company's stock worth $2,621,000 after purchasing an additional 1,448,200 shares in the last quarter.</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here